Freestone Capital Holdings, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1470876 Seattle, WA

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$358,504

-$415 QoQ

Shares Held

464

-0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

Freestone Capital Holdings, LLC holds $6,301,304 across 14 Biotechnology names. REGN ranks #5 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABUS	Arbutus Biopharma Corp	442,500	$1,991,250
2	IMNM	Immunome Inc.	61,514	$1,345,311
3	BNTX	BioNTech SE	7,914	$703,396
4	VRTX	Vertex Pharmaceuticals Inc / Ma	900	$401,886
5	REGN	Regeneron Pharmaceuticals, Inc. This page	464	$358,504
6	RYTM	Rhythm Pharmaceuticals, Inc.	3,700	$321,789
7	EXEL	Exelixis, Inc.	7,001	$300,272
8	RVMD	Revolution Medicines, Inc.	2,109	$205,100

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$358,504	464	-0.2%	Shares	Defined	2026-05-13
2025-12-31	$358,919	465	0.0%	Shares	Defined	2026-01-23
2025-09-30	$261,455	465	0.0%	Shares	Defined	2025-11-12
2025-06-30	$244,125	465	-13.6%	Shares	Defined	2025-08-05
2025-03-31	$341,215	538	-13.4%	Shares	Defined	2025-05-13
2024-12-31	$442,356	621	+1.5%	Shares	Defined	2025-02-06
2024-09-30	$643,358	612	+1.0%	Shares	Defined	2024-11-14
2024-06-30	$636,924	606	+2.4%	Shares	Defined	2024-11-22
2024-03-31	$569,794	592	—	Shares	Defined	2024-11-22
No filing history on record for this holder in this stock.